Savana, a Madrid-based medical company developing innovative AI technologies to unlock the clinical value in this data, raised $25 million in funding.

The round was led by Conexo Ventures, with the participation of Knuru Capital, Aldea Ventures, and existing investors Seaya Ventures and Cathay Innovation.

With the newly infused capital, the platform will increase its data analysis capabilities, to include new data layers (genomics, biomolecular data, or images), and tackle new sources of information (such as those generated during clinical trials). 

Company: MedSavana S.L.

Raised: $25.0M

Round: Unknown

Funding Month: April 2022

Lead Investors: Conexo Ventures 

Additional Investors: Knuru Capital, Aldea Ventures, Seaya Ventures, and Cathay Innovation

Company Website: https://savanamed.com/ 

Software Category: Electronic Health Records

About the Company: Founded in 2014, Savana is an international medical company that has developed a scientific methodology that applies Artificial Intelligence (AI) to unlock all the clinical value embedded within Electronic Health Records' free-text (EHRs). The Spanish health tech startup is using AI to provide medical knowledge based on ‘Real World Evidence’ to enhance research and build predictive models to enhance patients’ lives. The company provides doctors with life-saving insights by unlocking the critical information buried within the free text of clinical notes, which can then be analyzed jointly with systems biology information, allowing hospitals to optimize the research and development of new drugs.

Source: https://tech.eu/2022/04/05/savana-gets-25-million-booster-to-make-clinical-research-faster-and-more-powerful/